Holen Sie sich die Stockscreener-App
131.66
0.84%
-1.12
Handel nachbörslich:
131.55
-0.11
-0.08%
Schlusskurs vom Vortag:
$132.78
Offen:
$132.49
24-Stunden-Volumen:
6.44M
Relative Volume:
0.69
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.74%
1M Leistung:
-4.11%
6M Leistung:
+12.87%
1J Leistung:
+66.13%
1-Tages-Spanne:
$131.47
$134.29
1-Wochen-Bereich:
$125.07
$134.29
52-Wochen-Spanne:
$78.00
$139.19
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Firmenname
State Street Spdr S P Biotech Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare XBI vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
131.66 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
366.79 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
745.64 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
749.14 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
289.09 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
717.54 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Aktie (XBI) Neueste Nachrichten
Is State Street SPDR S&P Telecom ETF (XTL) a Strong ETF Right Now? - Yahoo Finance
Is State Street SPDR S&P Transportation ETF (XTN) a Strong ETF Right Now? - Yahoo Finance
If You Hold This Healthcare ETF, You’re Losing Big - 24/7 Wall St.
State Street SPDR S&P Biotech ETF (NY: XBI - FinancialContent
2 Ways to Play the Big Pharma Patent Cliff - Investing.com
Is State Street SPDR S&P Retail ETF (XRT) a Strong ETF Right Now? - Yahoo Finance
ETFs Investing in Ardelyx, Inc. Stocks - TradingView
Taiwan Semiconductor, Freeport-McMoRan And More On CNBC's 'Final Trades' - Benzinga
SPDR S&P Biotech ETF (XBI) Price Forecast: Long-Term Breakout Fuels Biotech Strength - FXEmpire
Locking in a quick gain in this biotech ETF made room for better swing trades; here's why - MSN
7 ETFs to Play a Healthcare Rebound - Barron's
TD (TD) prices callable contingent‑interest notes linked to KRE, SMH, XBI - Stock Titan
Why Is Moderna Stock Falling Friday?Moderna (NASDAQ:MRNA) - Benzinga
Is State Street SPDR S&P Biotech ETF (XBI) a strong ETF right now? - MSN
Gilead Sciences Crosses Critical Breakout Level. The Stock Can Gain 35% From Here. - Barron's
State Street SPDR S&P Biotech ETF (XBI) – Investment Case Analysis and Peer Benchmarking for 2026Shared Buy Zones - newser.com
Should you invest in the State Street SPDR S&P Biotech ETF (XBI)? - MSN
Sector alert: 4 healthcare ETFs poised for explosive growth now - MSN
This biotech is working on a GLP-1 pill that could be better than the Wegovy version - MSN
State Street SPDR S&P Biotech ETF (XBI) – Performance Review, Structural Profile, and Investment Suitability AssessmentHigh Attention Stocks - Newser
State Street SPDR S&P Biotech ETF (XBI) – Investment Merit Assessment for Biotech Sector ExposureExpert Stock Picks - Newser
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
Citigroup, Morgan Stanley, CBRE Group and more on CNBC's 'Final Trades' - MSN
Tech Leads, Dow Lags As Oil Holds Near $92: What's Moving Markets Wednesday? - Benzinga
Is State Street SPDR S&P Capital Markets ETF (KCE) a Strong ETF Right Now? - Yahoo Finance
Citigroup, Morgan Stanley, CBRE Group And More On CNBC's 'Final Trades' - Benzinga
Main Street Research LLC's State Street SPDR S&P Biotech ETF(XBI) Holding History - GuruFocus
Roundview Capital LLC's State Street SPDR S&P Biotech ETF(XBI) Holding History - GuruFocus
State Street SPDR S&p/asx Small Ordinaries ETFSSOStock Price & News - The Motley Fool
TD (NYSE: TD) offers callable contingent‑interest notes linked to KRE, KWEB, XBI - Stock Titan
iShares Biotechnology ETF (IBB) Stock Price, News, Quote & History - Yahoo! Finance Canada
XBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026 - 24/7 Wall St.
State Street SPDR S&P Biotech ETF (XBI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Neurocrine Buys Soleno To Tap High-Growth Rare Disease MarketNeurocrine Biosciences (NASDAQ:NBIX), Sol - Benzinga
Is State Street SPDR NYSE Technology ETF (XNTK) a Strong ETF Right Now? - Yahoo Finance
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It. - 24/7 Wall St.
$1000 Invested In State Street SPDR S&P Biotech ETF 20 Years Ago Would Be Worth This Much Today - Sahm
First Trust NYSE Arca Biotechnology Index Fund (FBT) stock price, news, quote and history - Yahoo Finance Singapore
VanEck Biotech ETF (BBH) stock price, news, quote and history - Yahoo Finance Singapore
Direxion Daily S&P Biotech Bull 3X Shares (LABU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs - Barron's
Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead - 24/7 Wall St.
Trade State Street SPDR S&P Biotech ETFXBI CFD - Capital.com
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Yahoo Finance
Atika Capital Management LLC's State Street SPDR S&P Biotech ETF(XBI) Holding History - GuruFocus
Stock List: Research Stocks from Around the World - GuruFocus
ETFs Investing in Novavax, Inc. Stocks - TradingView
ETFs Investing in Moderna, Inc. Stocks - TradingView
ADMA Jumps 15% in Late-Day Rally: Biotech Market Turbulence Escalates Amid Options Trading Momentum - Bitget
Finanzdaten der State Street Spdr S P Biotech Etf-Aktie (XBI)
Es liegen keine Finanzdaten für State Street Spdr S P Biotech Etf (XBI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):